KLOW 80mg - BPC-157 + GHK-CU 50mg + TB-500 10mg + KPV 10mg
Batch-Specific Certificates of Analysis (COAs)
Batch-specific COAs are included within the product image gallery for reference.
FOR RESEARCH USE ONLY
Intended Use
This product is supplied strictly for laboratory research use only.
Not for human or veterinary use.
The KLOW stack combines four bioactive peptides—BPC-157, TB-500 (a synthetic fragment of thymosin beta-4), GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), and KPV (lysine-proline-valine)—that have been investigated for their roles in tissue repair, inflammatory regulation, and cellular signaling. BPC-157 is a stable gastric pentadecapeptide studied for cytoprotective effects and its ability to modulate angiogenesis, nitric oxide signaling, and fibroblast activity. TB-500 has been examined for its influence on actin dynamics, cell migration, and inflammatory pathways, contributing to processes involved in tissue regeneration and wound repair. GHK-Cu is a naturally occurring copper-binding tripeptide associated with modulation of gene expression related to collagen synthesis, antioxidant defenses, and extracellular matrix remodeling. KPV, a tripeptide derived from the C-terminal sequence of α-melanocyte-stimulating hormone (α-MSH), has been investigated for its anti-inflammatory properties, including inhibition of pro-inflammatory cytokine signaling and regulation of immune cell activity. Collectively, this peptide combination has been explored in preclinical and experimental contexts for its potential effects on regenerative signaling pathways, vascular integrity, immune modulation, and structural protein turnover.
KLOW is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease, disorder, or medical condition.
KLOW is not intended for use as a therapeutic good, medicine, supplement, cosmetic, or injectable product and must not be represented as such.
Technical Specifications – KLOW
Product Composition
• KLOW Formulation: 80 mg
(Multi-component research formulation)
Component Breakdown (per vial):
• BPC-157 – 10 mg
• GHK-Cu – 50 mg
• TB-500 – 10 mg
• KPV – 10 mg
Total Contents: 80 mg
Presentation: Solid or lyophilized research material (single-vial formulation)
KLOW – Specification (80 mg)
• Name: KLOW
• Formulation Type: Multi-component research formulation
• Regulatory Status: Research use only (non-clinical, non-therapeutic)
Composition & Identity
• Description: Proprietary grouped research formulation
• Component Details: Refer to batch-specific COA
• Molecular Weights / Chemical Formulas: Refer to batch-specific COA
• CAS Numbers: Refer to batch-specific COA (where applicable)
(Component composition and analytical identifiers may vary by batch and are documented in the accompanying COA.)
Purity & Quality
• Purity: Component-dependent; analytical conformity verified per batch
• Verification Methods: Appropriate analytical techniques (e.g. HPLC, MS)
• Grade: Research grade (non-GMP, non-clinical)
Physical Characteristics
• Appearance: Solid or lyophilized powder
• Color: White to off-white (may vary by batch)
• Odor: Odorless or faint characteristic odor
Solubility
• Solubility characteristics vary by component and solvent system
• Solubility data provided in batch-specific COA where applicable
• Avoid exposure to extreme pH conditions or incompatible solvents
Storage & Stability
Storage:
• Store at –20 °C or below
• Protect from light, heat, and moisture
Stability:
• Stable under recommended storage conditions
• Minimize repeated temperature cycling or freeze–thaw exposure
Handling Notes
• Keep vial tightly sealed when not in use
• Handle using appropriate laboratory controls and PPE
• Avoid contamination and unnecessary environmental exposure
• Protect from heat, moisture, and direct light
Product Disclaimer
This product is supplied strictly for laboratory research use only. It has not been evaluated or approved by any regulatory authority, including but not limited to the FDA, EMA, MHRA, or Australian TGA, for human therapeutic, diagnostic, clinical, cosmetic, dietary, or veterinary applications.
No claims are made regarding the safety, efficacy, or suitability of this formulation for medical, therapeutic, cosmetic, or consumer use.
This product must not be ingested, injected, inhaled, implanted, applied topically, or administered to humans or animals under any circumstances.
The product is supplied “as is”, without any warranty—express or implied. The purchaser assumes full responsibility for proper handling, storage, use, and disposal in accordance with institutional policies and all applicable regulations.
